Importantly, the addition of Nutlin, an MDM4/MDM2 antagonist led to death of retinoblastoma cell lines and synergized with traditional chemotherapy in an orthotopic retinoblastoma mouse model [58,59]. Here, MDM4 is linked to retinoblastoma.